AHA Scientific Sessions 2025 Abstract

Proprotein Convertase Subtilisin/ Kexin Type 9 Inhibitors Improve Lipid Profile and May Stabilize Vasculopathy in Heart Transplant Recipients with Chronic Allograft Vasculopathy: A Pooled Analysis of Existing Studies

The paper

Gujranwala Medical College; King Edward Medical University

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4366569

doi.org/10.1161/circ.152.suppl_3.4366569